Case Studies
Medway Maritime Hospital, Medway NHS Trust
The Medway Maritime NHS Trust in was the first Trust to adopt the CardioQ technology on day to day surgery on a wide scale in 2004. It has reported potential savings of £3 million a year from using the technology and is already saving over £1 million per year. Medway was able to close 1.5 surgical wards partly as a result of the use of CardioQ and aims to open a 10 bed surgical High Dependency Unit in part of the space freed up. Andy Horne, the hospital's Chief Executive commented, "we have used CardioQ in around 200 operations in the last four months and had very good results. It has improved quality of care for patients as they are healthier when they leave theatre, need less post-operative care and get home quicker".
, Paisley, NHS Greater Health Board
The study conducted at the by Dr David Alcorn and his team in May 2006 involved 30 patients undergoing major colorectal surgery and aimed to discover whether patients' lengths of stay in hospital after surgery were reduced if their fluid status was optimised during surgery. It found that those patients who were treated with CardioQ had a mean length of stay of 9.55 days compared to 12 days for those patients that had received a standardised anaesthetic. This equates to a 20% reduction in the average length of post-operative hospital bed stay. Dr David Alcorn, a Consultant Anaesthetist, who was in charge of auditing the procedure at the hospital said, "we are greatly encouraged by the results achieved. This has major benefits not only for patients but for clinicians and hospitals throughout the country.?
Spread your message to an audience that counts, with options available for our website, email bulletins and publications including The House Magazine.
